WeVote
Log In

Bill

Bill

S 4323

Requires health insurance coverage of screening for Alzheimer's disease and related disorders for certain covered persons.

2024-2025 Regular Session Introduced by Jim Beach and 2 co-sponsors

New Jersey would require health insurers to cover Alzheimer's screening for certain populations, improving access but increasing insurance costs and debate over screening necessity.

Introduced in the Senate, Referred to Senate Commerce Committee
#disease #healthinsur
0
WeVote Research Nonpartisan
Bill Summary · S 4323

Legislative bill overview

S 4323 mandates that health insurance plans in New Jersey must cover screening tests for Alzheimer's disease and related cognitive disorders for eligible covered persons. The bill specifies which populations would qualify for this covered screening, likely based on age, risk factors, or other clinical criteria. This represents a requirement for insurers to include these diagnostic services as a covered benefit without cost-sharing barriers.

Why is this important

Alzheimer's disease and related dementias affect over 6 million Americans, with early detection potentially enabling earlier intervention and care planning. Insurance coverage requirements remove financial barriers to screening, which may increase diagnosis rates and allow families more time to prepare for disease progression. However, this also expands mandated insurance benefits, which typically increases insurance premiums for all policyholders.

Potential points of contention

  • Cost implications: Mandated benefits increase insurance premiums; unclear whether screening benefits justify costs for all insureds, including younger/lower-risk populations who may subsidize coverage for higher-risk groups
  • Screening efficacy debate: Medical evidence on the effectiveness and appropriate use of cognitive screening in asymptomatic populations varies; some argue screening without proven interventions may create anxiety without clinical benefit
  • Definition ambiguity: "Related disorders" and "certain covered persons" lack specificity—unclear which cognitive conditions qualify and which populations are eligible, potentially creating implementation disputes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.